{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:33:12Z","timestamp":1791113592089,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,15]]},"DOI":"10.1097\/tp.0b013e31824f3dae","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T06:33:59Z","timestamp":1333175639000},"page":"1125-1129","source":"Crossref","is-referenced-by-count":21,"title":["Acute Effects of Calcineurin Inhibitors on Kidney Allograft Microperfusion Visualized by Contrast-Enhanced Sonography"],"prefix":"10.1097","volume":"93","author":[{"given":"Lars P.","family":"Kihm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinzent","family":"Hankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Stoffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":". Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":". Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R3-10-20210129","first-page":"SS5","article-title":"Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors.","volume":"71","author":"Kreis","year":"2001","journal-title":"Transplantation"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/00007890-200206270-00013","article-title":". The changing causes of graft loss and death after kidney transplantation.","volume":"73","author":"Howard","year":"2002","journal-title":"Transplantation"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":". The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":". Immunosuppression: Evolution in practice and trends, 1994-2004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-199207000-00009","article-title":". Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation.","volume":"54","author":"Perico","year":"1992","journal-title":"Transplantation"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.TP.0000121196.71904.E0","article-title":". Oral cyclosporine but not tacrolimus reduces renal transplant blood flow.","volume":"77","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-2277.1998.tb00948.x","article-title":". Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.","volume":"11","author":"Radermacher","year":"1998","journal-title":"Transpl Int"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00007890-200203150-00012","article-title":". Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects.","volume":"73","author":"Klein","year":"2002","journal-title":"Transplantation"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1681\/ASN.V85813","article-title":". Determinants of intrarenal Doppler indices in stable renal allografts.","volume":"8","author":"Krumme","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa022602","article-title":". The renal arterial resistance index and renal allograft survival.","volume":"349","author":"Radermacher","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1111\/j.1600-6143.2006.01524.x","article-title":". Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients.","volume":"6","author":"Schwenger","year":"2006","journal-title":"Am J Transplant"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1600-6143.2005.01224.x","article-title":". Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy.","volume":"6","author":"Schwenger","year":"2006","journal-title":"Am J Transplant"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/TP.0b013e3181ac8cdd","article-title":". Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus.","volume":"88","author":"Kihm","year":"2009","journal-title":"Transplantation"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.transproceed.2004.08.109","article-title":". Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production.","volume":"36","author":"Watarai","year":"2004","journal-title":"Transplant Proc"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ki.1989.304","article-title":". Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects.","volume":"36","author":"Conte","year":"1989","journal-title":"Kidney Int"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-200207150-00016","article-title":"Detection of chronic allograft nephropathy by quantitative Doppler imaging.","volume":"74","author":"Nankivell","year":"2002","journal-title":"Transplantation"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0221-0363(05)81492-1","article-title":"Guidelines for the use of contrast agents in ultrasound.","volume":"86","author":"Tranquart","year":"2005","journal-title":"J Radiol"},{"key":"R20-10-20210129","first-page":"791","article-title":"Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations.","volume":"7","author":"McNally","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.CIR.88.3.1101","article-title":". Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation.","volume":"88","author":"Kaye","year":"1993","journal-title":"Circulation"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":". Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney Int"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004872-199715030-00014","article-title":". Cyclosporine-induced hypertension and decline in renal function in healthy volunteers.","volume":"15","author":"Hansen","year":"1997","journal-title":"J Hypertens"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.1985.196","article-title":"Effect of cyclosporine administration on renal hemodynamics in conscious rats.","volume":"28","author":"Murray","year":"1985","journal-title":"Kidney Int"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ki.1995.200","article-title":". Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.","volume":"47","author":"Textor","year":"1995","journal-title":"Kidney Int"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.82.23.8222","article-title":"Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.","volume":"82","author":"Moss","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0895-7061(00)00288-0","article-title":"Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension.","volume":"13","author":"Zhang","year":"2000","journal-title":"Am J Hypertens"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"29669","DOI":"10.1074\/jbc.M204519200","article-title":"Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A.","volume":"277","author":"Kou","year":"2002","journal-title":"J Biol Chem"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"48794","DOI":"10.1074\/jbc.M313897200","article-title":". Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.","volume":"279","author":"Lungu","year":"2004","journal-title":"J Biol Chem"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI117222","article-title":". Vascular mechanisms of cyclosporin-induced hypertension in the rat.","volume":"93","author":"Roullet","year":"1994","journal-title":"J Clin Invest"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-199211000-00002","article-title":". The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.","volume":"54","author":"Benigni","year":"1992","journal-title":"Transplantation"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.TP.0000148917.96653.E9","article-title":". Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.","volume":"79","author":"Cantarovich","year":"2005","journal-title":"Transplantation"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":". No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report.","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ndt\/14.2.384","article-title":". Renal effects of amlodipine in normotensive renal transplant recipients.","volume":"14","author":"Venkat Raman","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":". Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: A randomised trial.","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000137793.23371.42","article-title":". Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study.","volume":"78","author":"Kuypers","year":"2004","journal-title":"Transplantation"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.crad.2009.06.010","article-title":". Ultrasonic microbubble contrast agents and the transplant kidney.","volume":"64","author":"Kay","year":"2009","journal-title":"Clin Radiol"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-410X.2007.07280.x","article-title":". Acute pyelonephritis: Comparison of diagnosis with computed tomography and contrast-enhanced ultrasonography.","volume":"101","author":"Mitterberger","year":"2008","journal-title":"BJU Int"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/ndt\/gfq417","article-title":". Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients.","volume":"26","author":"Granata","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":". Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00007890-200205151-00003","article-title":". Patient management by Neoral C(2) monitoring: An international consensus statement.","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"R42-10-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2004-813245","article-title":". Guidelines for the use of contrast agents in ultrasound. January 2004.","volume":"25","author":"Albrecht","year":"2004","journal-title":"Ultraschall Med"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":". A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201206150-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:34:40Z","timestamp":1786048480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201206150-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31824f3dae","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}